Skip to content

Commit 59aa13a

Browse files
committed
Explore team April update
Edited formatting, added images
1 parent 68fa251 commit 59aa13a

3 files changed

Lines changed: 97 additions & 51 deletions

File tree

414 KB
Loading

app/posts/explore-team/2025/03/2025-03-12-what-we-learned-about-sharing-breast-and-bowel-results-with-gps.md

Lines changed: 1 addition & 1 deletion
Original file line numberDiff line numberDiff line change
@@ -195,7 +195,7 @@ There is still some work for us to do before we can scope the route to delivery:
195195

196196
* results printing in BSOs: what happens in those BSOs that print in-house and those that use ‘other’ types of outsourcing?
197197
* what are the intended and unintended consequences of a solution (eg for printing service providers) - we are collaborating with the transition team on this
198-
* what are the timeline, cost, complexity of each option - we are collaborating with the transition team and the [manage team](/manage-breast-screening/) on a single survey to BSOs; colleagues mentioned Lucy Jenkins' analysis that we should follow
198+
* what are the timeline, cost, complexity of each option - we are collaborating with the transition team and the [manage team](/manage-breast-screening/) on a single survey to BSOs
199199
* who and how will take this work forward, if, as we are learning, there is a benefit to delivering it?
200200

201201
## Next steps

app/posts/explore-team/2025/04/2025-04-25-finding-the-right-solution-for-sharing-breast-results-with-GPs.md

Lines changed: 96 additions & 50 deletions
Original file line numberDiff line numberDiff line change
@@ -16,104 +16,150 @@ We are learning how we can improve the sharing of screening results with GPs (se
1616

1717
Having looked at breast and bowel cancer screening services in some detail, we decided to narrow our focus to:
1818

19-
- breast screening over bowel cancer screening
20-
- normal and ‘did not attend’ (DNA) results over abnormal or other result types
19+
* breast screening over bowel cancer screening
20+
* normal and ‘did not attend’ (DNA) results over abnormal or other result types
2121

22-
We wrote about this in more detail in our previous update on [what we were learning](https://nhsdigitalcorporate.enterprise.slack.com/docs/T0FRZQSMB/F08PGETDG05?focus_section_id=temp:C:RVAa8d5cc0e0c3f43e78c216019d).
22+
We wrote about this in more detail in our previous update on [what we were learning](https://design-history.prevention-services.nhs.uk/explore-team/2025/01/sharing-screening-results-with-gps/).
2323

2424
![A 'breast care unit' sign on a sunny day](humberside-bso.jpeg "We visited the breast care unit at Humberside to learn more about their work")
2525

2626
## Why breast screening over bowel cancer screening?
2727

28-
- 99% of all normal results in bowel are already sent electronically
29-
- bowel cancer screening results use the ‘pathology’ route and are working well for GPs
28+
* 99% of all normal results in bowel are already sent electronically
29+
* bowel cancer screening results use the ‘pathology’ route and are working well for GPs
30+
31+
One GP practice staff member told us:
32+
33+
> “I’d like to see something like bowel coding.”
34+
35+
They showed us how easy it was to apply rules to bowel screening results and auto-file them:
3036

31-
One GP practice staff member told us:
32-
> “I’d like to see something like bowel coding,”
33-
and showed us how easy it was to apply rules to bowel screening results and auto-file them:
3437
> “You tick a box that correlates to the pathology screen, apply a really quick rule and it will autofile in 2 minutes.”
3538
39+
![Special perforated paper in a printer](perforated-paper-in-printer.jpg "Special perforated paper used for breast screening GP reports, kindly sent to us by one BSO")
40+
3641
## Being creative and pragmatic
3742

38-
While bowel pathology route is working well, breast screening results cannot just go the same route as bowel. [The ‘pathology’ route used by bowel](https://design-history.prevention-services.nhs.uk/explore-team/2025/03/what-we-learned-about-sharing-breast-and-bowel-results-with-gps/#how-results-are-shared%3A-bowel-screening) uses old technology that is marked for deprecation and is in the process of being upgraded.
43+
While bowel pathology route is working well, breast screening results cannot just follow the same route as bowel. [The ‘pathology’ route used by bowel](https://design-history.prevention-services.nhs.uk/explore-team/2025/03/what-we-learned-about-sharing-breast-and-bowel-results-with-gps/#how-results-are-shared%3A-bowel-screening) uses old technology that is marked for deprecation and is in the process of being upgraded.
3944

4045
A technical architect colleague told us:
41-
> “You could try to shoehorn it into an EDIFACT pathology message. Even if you can do it, you shouldn't.”
4246

43-
A designer colleague working in vaccinations told us:
44-
> “Be tactical — find an opening. What we have doesn’t match any diagram.”
47+
> “You could try to shoehorn it into an [EDIFACT](https://digital.nhs.uk/developer/api-catalogue/pathology-messaging-edifact) pathology message. Even if you can do it, you shouldn't.”
48+
49+
A designer colleague working in vaccinations told us:
50+
51+
> “Be tactical, find an opening. What we have doesn’t match any diagram.”
4552
4653
So, while we used some high-level solutions to encourage ideas, it will be up to the alpha team to decide, creatively and pragmatically, on the short-term solution. They would need to weigh it up against longer-term and adjacent solutions.
4754

4855
## The 3 Alpha team tracks
4956

5057
Because of this complex context, we suggest that the alpha team should work across 3 tracks:
5158

52-
- experiment track: can the team find a usable, viable and feasible solution?
53-
- approvals track: can the team get all the right approvals?
54-
- collaboration track: can the team coordinate with other teams whose work affects this work and vice versa?
59+
* experiment track: can the team find a usable, viable and feasible solution?
60+
* approvals track: can the team get all the right approvals?
61+
* collaboration track: can the team coordinate with other teams whose work affects this work and vice versa?
5562

5663
## Alpha team problem
5764

5865
We summarised the problem:
5966

60-
> 3 million breast screening results are sent annually to GP surgeries in paper and PDF formats. This leads to inaccurate screening data, high processing costs and worse patient care.
67+
3 million breast screening results are sent annually to GP surgeries in paper and PDF formats. This leads to inaccurate screening data, high processing costs and worse patient care.
6168

6269
Some trusts have started implementing their own solutions, but what they can do is limited — data from the 75 instances of the legacy NBSS is not readily available to them.
6370

64-
There is variation in how results are generated in each BSO. GP and patient results are not necessarily processed the same way, but both need to come from the same data source to ensure integrity.
71+
There is variation in how results are generated in each BSO (breast screening office). GP and patient results are not necessarily processed the same way, but both need to come from the same data source to ensure integrity.
6572

6673
## Alpha team brief
6774

68-
> Find the right combination of technologies to make normal and DNA breast screening results available to patients and GPs in a way that allows them to be added to patient records efficiently and accurately.
75+
Find the right combination of technologies to make normal and DNA breast screening results available to patients and GPs in a way that allows them to be added to patient records efficiently and accurately.
6976

7077
## Assumptions to invalidate
7178

7279
We say ‘invalidate’ because the goal is to experiment, test, learn and iterate to reduce risk. We have blind spots and the alpha team’s job is to explore them and to find what works.
7380

74-
| Assumptions | Evidence | Risk type | User or actor | Confidence |
75-
|------------|----------|-----------|----------------|-------------|
76-
| GPs, BSOs and NHSE need breast screening results to be automated | Qualitative feedback from GPs, BSOs and NHSE | value | GP, BSO, NHSE | high |
77-
| EMIS and TPP will be able to implement a solution within a reasonable timeframe | Total time to implement by GP IT is 18-24 months (6 months roadmap; 6-18 delivery) | feasibility | EMIS, TPP, DSIC | medium |
78-
| We can obtain patient and GP results within a reasonable timeframe | BS Select feedback that it is already possible; Screening working group set up | feasibility | DPSP | medium |
79-
| We can tag results with SNOMED CT codes within a reasonable timeframe | Several colleagues have done work to create breast screening SNOMED codes | feasibility | DPSP | medium |
80-
| All BSOs (including those using Synertec, Civica, in-house, ‘other’) will be able to transition to the new result process easily for patients (SMSTA) and GPs (SIL) | There are 75 instances of NBSS running locally in 77 BSOs, changes need to be implemented one by one. BSOs will be impacted differently depending on who handles their results (Synertec, Civica, in-house, ‘other’) | viability | BSO | low |
81-
| It is cheaper and quicker to build this short-medium term solution than to build a fundamental solution | Replacing NBSS with a new system may mean that BSOs are able to access results and find their own solution | viability | DPSP, BSOs | low |
82-
| Breast screening result data would be extracted into a central screening repository before being shared with GPs | Team MAYS is implementing a digital screening strategy that enables the extraction and centralisation of results data | feasibility | MAYs | medium |
81+
### GPs, BSOs and NHSE need breast screening results to be automated
82+
83+
* evidence: qualitative feedback from GPs, BSOs and NHSE
84+
* risk type: value
85+
* user or actor: GP, BSO, NHSE
86+
* confidence: high
87+
88+
### GP IT providers will be able to implement a solution within a reasonable timeframe
89+
90+
* evidence: total time to implement by GP IT is 18-24 months (6 months roadmap; 6-18 delivery)
91+
* risk type: feasibility
92+
* user or actor: EMIS, TPP, DSIC
93+
* confidence: medium
94+
95+
### We can obtain patient and GP results within a reasonable timeframe
96+
97+
* evidence: BS Select feedback that it is already possible; Screening working group set up
98+
* risk type: feasibility
99+
* user or actor: DPSP
100+
* confidence: medium
101+
102+
### We can tag results with SNOMED CT codes within a reasonable timeframe
103+
104+
* evidence: several colleagues have done work to create breast screening SNOMED codes
105+
* risk type: feasibility
106+
* user or actor: DPSP
107+
* confidence: medium
108+
109+
### All BSOs will be able to transition to the new result process easily for patients (SMSTA) and GPs (SIL)
110+
111+
* evidence: there are 75 instances of NBSS running locally in 77 BSOs, changes need to be implemented one by one. BSOs will be impacted differently depending on who handles their results (Synertec, Civica, in-house, ‘other’)
112+
* risk type: viability
113+
* user or actor: BSO
114+
* confidence: low
115+
116+
### It is cheaper and quicker to build this short-medium term solution than to build a fundamental solution
117+
118+
* evidence: replacing NBSS with a new system may mean that BSOs are able to access results and find their own solution
119+
* risk type: viability
120+
* user or actor: DPSP, BSOs
121+
* confidence: low
122+
123+
### Breast screening result data would be extracted into a central screening repository before being shared with GPs
124+
125+
* evidence: team MAYS is implementing a digital screening strategy that enables the extraction and centralisation of results data
126+
* risk type: feasibility
127+
* user or actor: MAYS
128+
* confidence: medium
129+
83130

84131
## Hypothesis
85132

86-
> We believe making normal and DNA breast screening results available to GPs in a structured format
87-
> will result in cheaper, faster and more accurate result processing, as well as more accurate uptake data
88-
> for BSOs, GPs, patients and the breast screening programme.
89-
>
90-
> We will know this is true when we receive quantitative and qualitative feedback from GPs, BSOs and patients that the new process is working better for them.
133+
**We believe** making normal and DNA breast screening results available to GPs in a structured format
134+
135+
**will result in** cheaper, faster and more accurate result processing, as well as more accurate uptake data
136+
**for** BSOs, GPs, patients and the breast screening programme.
137+
138+
**We will know this is true** when we receive quantitative and qualitative feedback from GPs, BSOs and patients that the new process is working better for them.
91139

92140
## The emergent user needs
93141

94-
As a GP administrator
95-
I need an easy way to process and file medical reports
96-
so that I can focus on providing care to patients
142+
There is a wide range of job roles within GP practices and BSOs. We are deliberately using broad user types ('GP administrator' and 'BSO') until we learn more.
143+
144+
### As a GP administrator
145+
**I need** an easy way to process and file medical reports
146+
**so that** I can focus on providing care to patients
97147

98-
As a GP administrator
99-
I need to identify patients who miss screening appointments
100-
so that I can understand their reasons and support them to attend
148+
**I need** to identify patients who miss screening appointments
149+
**so that** I can understand their reasons and support them to attend
101150

102-
As a BSO
103-
I need breast screening results to be reliably stored
104-
so that GPs and patients can access them when needed, rather than having to request this information from us
151+
### As a BSO
152+
**I need** breast screening results to be reliably stored
153+
**so that** GPs and patients can access them when needed, rather than having to request this information from us
105154

106-
As a BSO
107-
I need an easy, cost-effective and reliable way to share screening results with patients
108-
so that they feel reassured and know what, if any, action to take
155+
**I need** an easy, cost-effective and reliable way to share screening results with patients
156+
**so that** they feel reassured and know what, if any, action to take
109157

110-
As a BSO
111-
I need an easy, cost-effective and reliable way to share screening results with GPs
112-
so that the patient screening record is accurate for future screening
158+
**I need** an easy, cost-effective and reliable way to share screening results with GPs
159+
**so that** the patient screening record is accurate for future screening
113160

114-
As a BSO
115-
I need GPs to help identify people who haven’t attended screening
116-
so that GPs can encourage them to attend
161+
**I need GPs** to help identify people who haven’t attended screening
162+
**so that** GPs can encourage them to attend
117163

118164
## Next steps
119165

0 commit comments

Comments
 (0)